CHICAGO, Feb. 17, 2011 /PRNewswire/ — The method represented in
the Coherence L.L.C. patent integrates the measurement of a
respiratory arterial pressure wave (a blood wave that rises
and falls with exhalation and inhalation) into conventional blood
pressure readings to provide healthcare professionals and users
with diagnostic information regarding breathing effectiveness and
its effect on systemic blood pressure.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

This patent will be auctioned off at ICAP Ocean
Tomo’s Spring 2011 Live IP Auction on March 31, 2011 in New
York City.

Key Characteristics

The patent discloses the following:  

• This invention provides the means for a healthcare professional
  to assess the presence and   magnitude of the respiratory
  arterial pressure wave and advise patients of remedial action,
  specifically, learning to change dysfunctional breathing habits
  – the affect being increased circulatory effectiveness and
  decreased systemic blood pressure.
• There are two novel features of the invention:
  1. It assesses the magnitude of the respiratory arterial
     pressure wave itself, and
  2. It measures systolic and diastolic pressures at the peaks and
     valleys of the respiratory arterial pressure wave yielding
     increased accuracy of oscillometric measurement
• The assessment and characterization of the respiratory
  arterial pressure wave is then employed by the user or
  healthcare professional to change breathing habits with the goal of
  realizing reduced blood pressure and improved health.
• A breathing pattern generator that teaches the correct
  breathing frequency and rhythm is also specified.

Market Potential<

‘/>”/>

SOURCE